FXR1 and cancer: Our verification of FXR1 overexpression in numerous types of tumors, with some results corroborated by previous studies, supports this perspective.[6,14–16] The prognostic implications and potential impact on tumorigenic processes of FXR1 expression levels in various human cancers remain unexplored and necessitate additional research.